Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-24 @ 3:17 PM
NCT ID:
NCT01024192
Brief Summary:
Primary Objective:
To evaluate the efficacy and safety of the use of Stilnox CR in Mexican patients with chronic insomnia at the prescription conditions of daily practice
Secondary Objective:
To evaluate the satisfaction of the patient with chronic insomnia with Stilnox CR over an as needed basis.
Study:
NCT01024192
Study Brief:
Protocol Section:
NCT01024192